Live Breaking News & Updates on Wenshe Ray Liu|Page 2

Stay updated with breaking news from Wenshe ray liu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Drug Shows Promise As COVID-19 Treatment

New Drug Shows Promise As COVID-19 Treatment
nbcdfw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcdfw.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Wenshe Ray Liu , Texasam University , Texasam University System , Sorrento Therapeutics ,

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , South Africa , United Kingdom , Alexis Nahama , Henry Ji , Wenshe Ray Liu , Indian Delta , Semnur Pharmaceuticals Inc , Texasam University , Exchange Commission , Sorrento Therapeutics Inc , Corporate Development , Scilex Pharmaceuticals Inc , Texasam University System , Sorrento Therapeutics , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Investor Relations , Semnur Pharmaceuticals , Scilex Pharmaceuticals , All Rights ,

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University

Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United States , South Africa , United Kingdom , Alexis Nahama , Henry Ji , Wenshe Ray Liu , Indian Delta , Semnur Pharmaceuticals Inc , Texasam University , Exchange Commission , Sorrento Therapeutics Inc , Corporate Development , Scilex Pharmaceuticals Inc , Texasam University System , Sorrento Therapeutics , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Investor Relations , Semnur Pharmaceuticals , Scilex Pharmaceuticals , All Rights ,

COVID-19: Angina drug may be an effective treatment


COVID-19: Angina drug may be an effective treatment
Written by Erika Watts on February 26, 2021 Fact checked by Hilary Guite, FFPH, MRCGP
New research in cells shows the drug bepridil holds promise for treating COVID-19. filadendron/Getty Images
A recent study shows that bepridil a drug approved by the Food and Drug Administration (FDA) for treating heart angina but currently voluntarily withdrawn due to cardiac side effects may be highly effective in treating COVID-19.
The researchers tested 55 different FDA-approved medications. As many as 29 of these showed promise, and six were found to reduce activity of a crucial enzyme that helps the virus replicate. ....

United States , University Of Texas , Wenshe Ray Liu , Kent Tseng , University Of Texas Medical Branch At Galveston , Texasam University , Drug Administration , College Station , National Academy , Gradipore Chair , Chien Te Kent Tseng , Texas Medical Branch , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் , கேண்ட் ட்செங் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை இல் கால்வெஸ்டன் , கல்லூரி நிலையம் , தேசிய கலைக்கழகம் , சீன் தே கேண்ட் ட்செங் , டெக்சாஸ் மருத்துவ கிளை ,